Author Correction: Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy

Author Correction: Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy

Bibliographic Details
Main Authors:	Ke-Qiong Deng, Aibing Wang, Yan-Xiao Ji, Xiao-Jing Zhang, Jing Fang, Yan Zhang, Peng Zhang, Xi Jiang, Lu Gao, Xue-Yong Zhu, Yichao Zhao, Lingchen Gao, Qinglin Yang, Xue-Hai Zhu, Xiang Wei, Jun Pu, Hongliang Li
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-05-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-023-38331-w

Similar Items

Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy
by: Ke-Qiong Deng, et al.
Published: (2016-06-01)

Ganoderma lucidum polysaccharides attenuates pressure-overload-induced pathological cardiac hypertrophy
by: Changlin Zhen, et al.
Published: (2023-03-01)

ANGPTL8 is a negative regulator in pathological cardiac hypertrophy
by: Lin Hu, et al.
Published: (2022-07-01)

A high-throughput drug screening identifies luteolin as a therapeutic candidate for pathological cardiac hypertrophy and heart failure
by: Zhenya Wang, et al.
Published: (2023-03-01)

E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING
by: Lu-Lu Yang, et al.
Published: (2022-10-01)

Treatment of myocardial interstitial fibrosis in pathological myocardial hypertrophy
by: Fuyu Zhu, et al.
Published: (2022-09-01)

Mitochondria in Pathological Cardiac Hypertrophy Research and Therapy
by: Dan Yang, et al.
Published: (2022-01-01)

Roles for the IKK-Related Kinases TBK1 and IKKε in Cancer
by: Joel K. Durand, et al.
Published: (2018-09-01)

Left ventricular hypertrophy, carotid atherosclerosis, and cognitive impairment in peritoneal dialysis patients
by: Xuejing Zhu, et al.
Published: (2023-03-01)

Factor inhibiting HIF negatively regulates antiviral innate immunity via hydroxylation of IKKϵ
by: Xiaolian Cai, et al.
Published: (2024-02-01)

Factor inhibiting HIF negatively regulates antiviral innate immunity via hydroxylation of IKKϵ
by: Xiaolian Cai, et al.
Published: (2024-01-01)

Ikke skrivekyndig?
by: Mia Franzisca Fasting
Published: (2022-11-01)

Toll-like receptors in cardiac hypertrophy
by: Yanan Zhang, et al.
Published: (2023-04-01)

Protections of transcription factor BACH2 and natural product myricetin against pathological cardiac hypertrophy and dysfunction
by: Xueli Jiang, et al.
Published: (2022-08-01)

The roles of the tumor suppressor parafibromin in cancer
by: Hua-chuan Zheng, et al.
Published: (2022-09-01)

Pathological hypertrophy reverses β2‐adrenergic receptor‐induced angiogenesis in mouse heart
by: Xu, Q, et al.
Published: (2015)

IKK 203-IKK 205 - OPERASI UNIT I APRIL 1998.
by: PPTI, Pusat Pengajian Teknologi Industri
Published: (1998)

IKK 204-IKK 304 - OPERASI UNIT II SEPT 1999.
by: PPTI, Pusat Pengajian Teknologi Industri
Published: (1999)

IKK 203/4,IKK 205/3 - Operasi Unit I
by: PPTI, Pusat Pengajian Teknologi Industri
Published: (1998)

IKK 204/2 & IKK304/2 - Operasi Unit II
by: PPTI, Pusat Pengajian Teknologi Industri
Published: (1998)

Regression of Left Ventricular Hypertrophy in Patients Combined with Peritoneal Dialysis and Hemodialysis
by: Gao Luyan, et al.
Published: (2022-01-01)

DEF6(differentially exprehomolog) exacerbates pathological cardiac hypertrophy via RAC1
by: Yan Sun, et al.
Published: (2023-07-01)

Therapeutic potentials of modulating autophagy in pathological cardiac hypertrophy
by: Shenggan Shi, et al.
Published: (2022-12-01)

Progress in the study of the epigenetic regulation of cardiac hypertrophy
by: ZHENG Jing-jing, BU Ning, ZHAO Zhao, ZHANG Jia-jing, YU Hui, ZHAO Yu-hang
Published: (2022-03-01)

IKK 101-IKK 201-3 - PENGHITUNGAN PROSES KIMIA APRIL 1998.
by: PPTI, Pusat Pengajian Teknologi Industri
Published: (1998)

IKK 204 DAN IKK 304 - OPERASI UNIT II APRIL 1998.
by: PPTI, Pusat Pengajian Teknologi Industri
Published: (1998)

IKK 204 DAN IKK 304 - OPERASI UNIT II APRIL 2000.
by: PPTI, Pusat Pengajian Teknologi Industri
Published: (2000)

Hvorfor samtalen ikke er demokratiets sjæl ikke er demokratiets sjæl
by: Michael Schudson
Published: (2001-09-01)

Inhibition of Cardiomyocytes Hypertrophy by Resveratrol Is Associated with Amelioration of Endoplasmic Reticulum Stress
by: Yan Lin, et al.
Published: (2016-07-01)

HIPK1 Inhibition Protects against Pathological Cardiac Hypertrophy by Inhibiting the CREB‐C/EBPβ Axis
by: Yihua Bei, et al.
Published: (2023-06-01)

The MGF300-2R protein of African swine fever virus is associated with viral pathogenicity by promoting the autophagic degradation of IKKα and IKKβ through the recruitment of TOLLIP.
by: Tao Wang, et al.
Published: (2023-08-01)

IKK 201-IKK 101-IEK 101 - PENGHITUNGAN PROSES KIMIA SEPT 1999.
by: PPTI, Pusat Pengajian Teknologi Industri
Published: (1999)

Targeting IKKβ in Cancer: Challenges and Opportunities for the Therapeutic Utilisation of IKKβ Inhibitors
by: Jack A. Prescott, et al.
Published: (2018-08-01)

”Man behøver ikke at være dum, bare fordi man ikke siger noget”
by: Karin Løvenskjold Svejgaard, et al.
Published: (2019-12-01)

Global Profile of tRNA-Derived Small RNAs in Pathological Cardiac Hypertrophy Plasma and Identification of tRF-21-NB8PLML3E as a New Hypertrophy Marker
by: Jingyi Xu, et al.
Published: (2023-06-01)

Circadian disruption during fetal development promotes pathological cardiac remodeling in male mice
by: Yang Yu, et al.
Published: (2024-02-01)

SUMOylation of TEAD1 Modulates the Mechanism of Pathological Cardiac Hypertrophy
by: Xin Shi, et al.
Published: (2024-03-01)

Non-Coding RNAs in the Therapeutic Landscape of Pathological Cardiac Hypertrophy
by: Joana Silva, et al.
Published: (2022-05-01)

Exercise training attenuates hypertension and cardiac hypertrophy by modulating neurotransmitters and cytokines in hypothalamic paraventricular nucleus.
by: Lin-Lin Jia, et al.
Published: (2014-01-01)

Anti-inflammatory therapy of atherosclerosis: focusing on IKKβ
by: Jiali Gan, et al.
Published: (2023-02-01)